|
|
|
|
LEADER |
01942nam a2200349 a 4500 |
001 |
1894553 |
005 |
20171111234724.0 |
008 |
030811s2003 dcu ob 000 0 eng d |
020 |
|
|
|a 0309503744
|q (electronic bk.)
|
020 |
|
|
|a 9780309503747
|q (electronic bk.)
|z 0309086264
|q (pbk.)
|q (pbk.)
|
040 |
|
|
|a N$T
|b eng
|e pn
|z 9780309086264
|
050 |
|
4 |
|a RA644.A6
|b A87 2003eb
|
240 |
1 |
0 |
|a CDC anthrax vaccine safety and efficacy research program
|
245 |
0 |
3 |
|a An assessment of the CDC anthrax vaccine safety and efficacy research program /
|c Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Medical Follow-up Agency, Institute of Medicine of The National Academies.
|
246 |
3 |
0 |
|a CDC anthrax vaccine safety and efficacy research program
|
260 |
|
|
|a Washington, DC :
|b National Academies Press,
|c ©2003.
|
300 |
|
|
|a 1 online resource (xvii, 160 pages)
|
504 |
|
|
|a Includes bibliographical references.
|
505 |
0 |
|
|a 1. Introduction -- 2. Background -- 3. The CDC anthrax vaccine research plan -- 4. Proposed studies on the efficacy of the anthrax vaccine -- 5. Proposed studies on the safety of the anthrax vaccine -- 6. Proposed studies on the acceptability of the anthrax vaccine -- 7. Summary assessment of the CDC anthrax vaccine research plan.
|
650 |
|
0 |
|a Anthrax
|x Vaccination
|z United States.
|x Research
|
650 |
|
2 |
|a Anthrax
|x prevention & control.
|
650 |
|
2 |
|a Anthrax Vaccines.
|
650 |
|
2 |
|a Drug Evaluation.
|
650 |
|
4 |
|a Anthrax
|x Vaccination.
|
650 |
|
4 |
|a Public health.
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|
650 |
|
7 |
|a Anthrax
|x Vaccination.
|
650 |
|
7 |
|a Public health.
|
651 |
|
2 |
|a United States.
|
710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program.
|
856 |
4 |
0 |
|u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=86870
|
952 |
|
|
|a CY-NiOUC
|b 5a0464c06c5ad14ac1eebc2e
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|